Understanding the Connection Between Polyneuropathy and hATTR Amyloidosis

“I have to be my own advocate, and you should be too,” said Christine, living with hereditary ATTR (hATTR) amyloidosis. “Once you know something, you can deal with it head-on. It’s the ‘not knowing’ that’s the most frustrating. Knowledge is power!” Christine shared her inspiring story about being diagnosed with and living with hATTR amyloidosis […]

Read More… from Understanding the Connection Between Polyneuropathy and hATTR Amyloidosis

Have you been diagnosed with CIDP? A clinical research study (ARISE) is now enrolling to evaluate an investigational medication.

Chronic inflammatory demyelinating polyneuropathy (CIDP) is a rare disease where the body’s natural defenses, like antibodies, attack the covering of the nerves, called myelin, and damage nerve function. While symptoms aren’t the same for everyone, CIDP can make your arms and legs feel weak and slow your movements. The purpose of the ARISE Study is […]

Read More… from Have you been diagnosed with CIDP? A clinical research study (ARISE) is now enrolling to evaluate an investigational medication.

PERIPHERAL NEUROPATHY RESEARCHERS INVITED TO PRE-APPLY FOR RESEARCH GRANTS FROM DoD PEER REVIEWED MEDICAL RESEARCH PROGRAM

The Foundation for Peripheral Neuropathy and the Department of Defense Peer-Reviewed Medical Research Program Co-Host March 8, 2023, Webinar About Award Pre-Applications CHICAGO, Feb. 28, 2023 /PRNewswire/ — For the third consecutive year, peripheral neuropathy (PN) has been renewed for research funding by the Department of Defense (DoD) Peer Reviewed Medical Research Program (PRMRP)’s $370 million fund. In advance of pre-application deadlines, the Foundation for Peripheral Neuropathy (FPN) […]

Read More… from PERIPHERAL NEUROPATHY RESEARCHERS INVITED TO PRE-APPLY FOR RESEARCH GRANTS FROM DoD PEER REVIEWED MEDICAL RESEARCH PROGRAM

Call to Action 2023 – Peer Reviewed Medical Research Program!

What It Is In response to the tireless advocacy and outreach from the peripheral neuropathy (PN) community, Congress designated peripheral neuropathy as a condition in the Peer Reviewed Medical Research Program (PRMRP) in the annual Defense Appropriations Act during fiscal years 2021 through 2023. During that time, the Department of Defense funded more than $13 million in […]

Read More… from Call to Action 2023 – Peer Reviewed Medical Research Program!

AAN’s New Painful Diabetic Polyneuropathy Guidelines

A study entitled “Oral and Topical Treatment of Painful Diabetic Polyneuropathy: Practice Guideline Update Summary” was published on December 29, 2021, in the journal Neurology®. The Foundation for Peripheral Neuropathy (FPN) is pleased to announce that Lindsay Colbert, Executive Director, was among the few esteemed authors on the subcommittee for this important review and update. […]

Read More… from AAN’s New Painful Diabetic Polyneuropathy Guidelines

PNRR Study on Vitamin B6

Vitamin B6 toxicity is known to be a cause of peripheral neuropathy. There is debate regarding the threshold at which intake levels can cause neurological symptoms through vitamin B6. In a 2021 study from the Peripheral Neuropathy Research Registry (PNRR), funded by the Foundation for Peripheral Neuropathy, researchers asked if elevated plasma vitamin B6 levels […]

Read More… from PNRR Study on Vitamin B6

FPN Welcomes New Board Member, Kristy Townsend

The Foundation for Peripheral Neuropathy is pleased to welcome our newest Member of the Board of Directors, Kristy Townsend, Ph.D., effective June 1, 2021. Kristy Townsend holds a Ph.D. in Neuroscience and has been investigating the brain and nervous system in the regulation of energy balance and metabolism for the past 20 years. Townsend is […]

Read More… from FPN Welcomes New Board Member, Kristy Townsend

FPN Welcomes the University of Michigan and Dr. Amro Stino

The Foundation for Peripheral Neuropathy (FPN) is pleased to welcome the University of Michigan as a new site for patient enrollments into the Peripheral Neuropathy Research Registry. In this article, FPN’s Executive Director interviews the newest researcher to join this special team, Dr. Amro Stino, and why this new partnership will be fruitful for the […]

Read More… from FPN Welcomes the University of Michigan and Dr. Amro Stino

Ask the Expert: Popular Questions from PN Patients

Following the Foundation for Peripheral Neuropathy‘s (FPN) recent webinar on current research trends, Lindsay Colbert, FPN’s Executive Director, caught up with the program’s panelists, Dr. Senda Ajroud-Driss, Dr. Ahmet Höke and Dr. Gordon Smith to follow-up on some important questions that the program did not have time to cover. In this “Ask the Expert” series, […]

Read More… from Ask the Expert: Popular Questions from PN Patients